Kathleen Kruse MD
Child & Adolescent Psychiatry, Forensic Psychiatry
Physician
Join to View Full Profile
1500 E Medical Center DrAnn Arbor, MI 48109
Phone+1 734-647-5299
Dr. Kruse is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Kruse is a board-certified psychiatrist, child & adolescent psychiatrist, and forensic psychiatrist based in Ann Arbor, MI. She is affiliated with Michigan Medicine. Her professional interests include child welfare and juvenile justice, health justice and criminal justice reform, mental health diversion, and neurodevelopmental disorders in forensic populations.
Education & Training
Case Western Reserve University/University Hospitals Cleveland Medical CenterFellowship, Forensic Psychiatry, 2020 - 2021
University of MichiganFellowship, Child and Adolescent Psychiatry, 2018 - 2020- University of MichiganResidency, Psychiatry, 2015 - 2018
University of Michigan Medical SchoolClass of 2015
Kalamazoo CollegeBA, Biology, Magna Cum Laude, 2007 - 2011
Certifications & Licensure
MI State Medical License 2018 - 2028
OH State Medical License 2020 - 2026
American Board of Psychiatry and Neurology Psychiatry- American Board of Psychiatry and Neurology Child & Adolescent Psychiatry
- American Board of Psychiatry and Neurology Forensic Psychiatry
Awards, Honors, & Recognition
- Chief Resident of Education Michigan Medicine, Child & Adolescent Psychiatry Department, 2019-2020
- Kenneth Chamberlain, MD, Medical Student Scholarship Award University of Michigan Medical School, Department of Psychiatry, 2015
- Phi Beta Kappa National Honor Society 2011
- Join now to see all
Publications & Presentations
PubMed
- 7 citationsThe effect of a computerized best practice alert system in an outpatient setting on metabolic monitoring in patients on second-generation antipsychotics.Sydnee Cohen, Jolene R. Bostwick, Vincent D. Marshall, Kathleen Kruse, Gregory W. Dalack
Journal of Clinical Pharmacy and Therapeutics. 2020-08-07
Professional Memberships
- Member
- Member
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
